AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PTC THERAPEUTICS, INC. Director's Dealing 2014

Dec 5, 2014

31046_dirs_2014-12-05_be50eb0d-d043-4cae-bf38-f050c0865143.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2014-12-04

Reporting Person: Almstead Neil Gregory (Senior VP, Research and CMC)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-04	Common Stock	S	175	$50.00	Disposed	1374	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	29881	Direct

Footnotes

F1: The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the spouse of the reporting person on December 4, 2013.